Genetic Landscape of Kawasaki Disease: An Update
Lymphatics · 20.07.2025 · 3 (3) · 21
DOI: 10.3390/lymphatics3030021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lymphatics, online erschienen am 20.07.2025. Verfasst von Taru Goyal und 13 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Kawasaki disease (KD), first identified in 1967 by Dr. Tomisaku Kawasaki, is an acute, self-limited vasculitis and remains the leading cause of acquired heart disease in children worldwide, particularly affecting those under the age of five. Clinically, it presents with persistent fever, mucocutaneous inflammation, skin rashes, and lymphadenopathy, with a marked tendency to involve the coronary arteries, potentially leading to serious complications such as coronary artery aneurysms. Despite extensive research spanning more than five decades, the precise etiology of KD remains unclear. However, accumulating evidence supports the significant role of genetic predisposition, highlighting the contribution of inherited factors in modulating immune responses and influencing disease susceptibility and severity. Emerging evidence highlights genetic susceptibility as pivotal, with genome-wide studies identifying polymorphisms in immune-related genes, such as ITPKC, CASP3, BLK, CD40, and ORAI1, which modulate disease risk and coronary complications. Epigenetic mechanisms, including DNA methylation and non-coding RNAs, bridge the gap between genetic and environmental factors, regulating immune responses and endothelial activation. Furthermore, emerging insights into autophagy-related processes provide a deeper understanding of the molecular mechanisms underlying the disease. This review aims to explore the current knowledge on the genetic landscape of KD, examine how these findings contribute to our understanding of its pathophysiology, and investigate the potential for genetically targeted therapeutic strategies in the future.
Förderung
- Indian Council of Medical Research
Zitieren
APA
Goyal, T., Sharma, S., Pilania, R. K., Jawallia, K., Chawla, S., Sharma, M., Rawat, M., Thakur, V., Arya, U., Kumar, A., Dhaliwal, M., Pandiarajan, V., Rawat, A., & Singh, S. (2025). Genetic Landscape of Kawasaki Disease: An Update. Lymphatics, 3(3), 21. https://doi.org/10.3390/lymphatics3030021
Vancouver
Goyal T, Sharma S, Pilania RK, Jawallia K, Chawla S, Sharma M, et al. Genetic Landscape of Kawasaki Disease: An Update. Lymphatics. 2025;3(3):21. doi:10.3390/lymphatics3030021
BibTeX
@article{Goyal2025,
author = {Goyal, Taru and Sharma, Saniya and Pilania, Rakesh Kumar and Jawallia, Kajol and Chawla, Sanchi and Sharma, Madhubala and Rawat, Monica and Thakur, Vaishali and Arya, Urvi and Kumar, Anoop and Dhaliwal, Manpreet and Pandiarajan, Vignesh and Rawat, Amit and Singh, Surjit},
title = {Genetic Landscape of Kawasaki Disease: An Update},
journal = {Lymphatics},
year = {2025},
volume = {3},
number = {3},
pages = {21},
doi = {10.3390/lymphatics3030021}
}
EUVIMED